Trade OncoCyte Corporation - OCX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0542 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.2729 |
| Open | 3.2429 |
| 1-Year Change | -18.08% |
| Day's Range | 3.2429 - 3.3829 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 3.2929 | 0.1400 | 4.44% | 3.1529 | 3.3229 | 3.1529 |
| Jul 24, 2024 | 3.1529 | 0.0200 | 0.64% | 3.1329 | 3.2329 | 3.1329 |
| Jul 23, 2024 | 3.2129 | 0.1200 | 3.88% | 3.0929 | 3.2429 | 3.0929 |
| Jul 22, 2024 | 3.1629 | -0.0500 | -1.56% | 3.2129 | 3.2629 | 3.0729 |
| Jul 19, 2024 | 3.2029 | 0.1400 | 4.57% | 3.0629 | 3.2129 | 3.0629 |
| Jul 18, 2024 | 3.1129 | -0.0700 | -2.20% | 3.1829 | 3.2229 | 3.0529 |
| Jul 17, 2024 | 3.2529 | -0.0500 | -1.51% | 3.3029 | 3.3129 | 3.1129 |
| Jul 16, 2024 | 3.2829 | -0.0600 | -1.79% | 3.3429 | 3.3829 | 3.2129 |
| Jul 15, 2024 | 3.3729 | 0.0300 | 0.90% | 3.3429 | 3.4329 | 3.2529 |
| Jul 12, 2024 | 3.2729 | 0.1300 | 4.14% | 3.1429 | 3.4329 | 3.1029 |
| Jul 11, 2024 | 3.1429 | 0.1900 | 6.43% | 2.9529 | 3.1529 | 2.9229 |
| Jul 10, 2024 | 2.9829 | 0.0800 | 2.76% | 2.9029 | 2.9829 | 2.9029 |
| Jul 9, 2024 | 2.9329 | -0.0400 | -1.35% | 2.9729 | 2.9829 | 2.9129 |
| Jul 8, 2024 | 2.9929 | 0.0400 | 1.35% | 2.9529 | 3.0329 | 2.9529 |
| Jul 5, 2024 | 3.0129 | 0.0400 | 1.35% | 2.9729 | 3.0129 | 2.9029 |
| Jul 3, 2024 | 3.0129 | 0.1200 | 4.15% | 2.8929 | 3.0629 | 2.8929 |
| Jul 2, 2024 | 2.9429 | 0.1000 | 3.52% | 2.8429 | 3.0429 | 2.8029 |
| Jul 1, 2024 | 2.9429 | 0.0400 | 1.38% | 2.9029 | 3.0429 | 2.8629 |
| Jun 28, 2024 | 2.9229 | 0.0700 | 2.45% | 2.8529 | 2.9329 | 2.7329 |
| Jun 27, 2024 | 2.8329 | 0.2500 | 9.68% | 2.5829 | 2.8929 | 2.5829 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
OncoCyte Corporation Company profile
About OncoCyte Corp
Oncocyte Corporation is a molecular diagnostics company. The Company is engaged in developing and commercializing laboratory-developed tests (LDTs) to serve unmet medical needs across the cancer care continuum. The LTDs provide actionable information to physicians and patients to optimize treatment decisions, including the selection of immunotherapy. The Company focuses on the development of a non-invasive confirmatory blood test for lung cancer called DetermaDx. The DetermaDx is the test to predict a post-surgery patient’s risk of cancer recurrence and their response to chemotherapy in early-stage lung cancer. Its development pipeline includes TheraSure CNI Monitor, which is a blood-based test for immunotherapy monitoring, and TheraSure Transplant Monitor, a solid organ transplantation monitoring test. Its other DetermaIO, DetermaCNI, DetermaMx, Keytruda, Opdivo, Tecentriq and Imfinzi.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, OncoCyte Corp revenues increased from $1.2M to $7.7M. Net loss increased from $29.9M to $64.1M. Revenues reflect DetermaRx segment increase from $547K to $2.5M, Pharma Services segment increase from $669K to $1.5M, United States segment increase from $742K to $3.5M. Higher net loss reflects Fair Value Adjustments on Other Assets increase from $4M (income) to $27.3M (expense).
| Industry: | Bio Therapeutic Drugs |
15 Cushing
IRVINE
CALIFORNIA 92618
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com